Donald Trump

  • Ways to solve the current bond conundrum

    Ways to solve the current bond conundrum

    Short duration or long duration? That is the question. And the answer, for past few years, has been ‘long’. It’s worked a treat for some. Could things be about to change or is the raging 30-year plus bull market going to go on for longer?

  • PA ANALYSIS: Should bears buy bond proxies on weakness?

    PA ANALYSIS: Should bears buy bond proxies on weakness?

    If a week is a long time in politics, then in markets it can make or break a trader, while heightening the contrarian instincts of investors with a longer-term view.

  • PA OPINION: Why the dollar bulls are mistaken

    PA OPINION: Why the dollar bulls are mistaken

    The dollar has rallied in recent days as investors believe stronger US GDP growth and Fed rate hikes will push the greenback up. But markets are ignoring the forces that are likely to drag the dollar down in the longer term.

  • PA ANALYSIS: With the election over Trump risk heads east

    PA ANALYSIS: With the election over Trump risk heads east

    Winter is coming, but instead of flying south the flock of black swans that has pecked away at 30 years of globalisation this year is heading east toward Europe.

  • Are ESG funds doomed to fail under Trump?

    Are ESG funds doomed to fail under Trump?

    President-elect Donald Trump might not be all bad for funds that make impactful investments in clean energy, technology or innovative pharmaceuticals, says AXA Investment Managers global head of responsible investment Matt Christensen.

  • PA ANALYSIS: Volatility here to stay in the age of the ‘Toblerone’ market

    PA ANALYSIS: Volatility here to stay in the age of the ‘Toblerone’ market

    Ever get the feeling you’ve been cheated? As I write, the masses are rebelling against a momentous decision that has thrown the free world off its axis… and that’s just the changing shape of the Toblerone.

  • AstraZeneca’s lower profits bitter pill to swallow

    AstraZeneca’s lower profits bitter pill to swallow

    Shares were down 2.5% to 4,461.5p late Thursday morning, following reports the pharmaceutical group’s pre-tax profits had slipped 29%.

  • PA Podcast: Balanced portfolios in an unbalanced world

    PA Podcast: Balanced portfolios in an unbalanced world

    John Wyn Evans, head of investment strategy at Investec Wealth and Investment talks the Trump, general geopolitical risk and the importance of reducing one’s return assumptions within balanced portfolios.

  • PA ANALYSIS: Inflationary fears as Trump victory spooks bond investors

    PA ANALYSIS: Inflationary fears as Trump victory spooks bond investors

    Bond investors are strapped in for an explosive month ahead as more questions were raised over the next Fed rate rise, following today’s US election result.

  • Trump or Clinton – how should you position your portfolio?

    Trump or Clinton – how should you position your portfolio?

    Fund managers and fund selectors alike are haunted by the prospect of Trumpian rule, but still deem a Clinton victory more likely. However, it’s paramount investors don’t leave themselves too exposed to the consequences of a Trump triumph.

  • PA OPINION: Greater diversity cannot come soon enough

    PA OPINION: Greater diversity cannot come soon enough

    There is an aspirational timbre to the slogan “Make America great again” that belies its dog-whistle like nature.

  • PA ANALYSIS: Weighing up White House risk

    PA ANALYSIS: Weighing up White House risk

    With less than a week to go before one of the most contentious presidential contests concludes, some market participants are ignoring the noise, but many are fretting over shocks to equity markets and the potential fallout from protectionist trade policies.